{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:23:42Z","timestamp":1793291022064,"version":"4.5.0"},"reference-count":243,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>B lymphocytes play a critical role in the pathogenesis of nephrotic syndrome (NS). This comprehensive review explores the phenotypic characteristics, pathogenic mechanisms, and clinical translational value of B cell subsets in different types of nephrotic syndrome. Studies demonstrate that B cells participate in disease development through multiple mechanisms, including autoantibody production, T cell function regulation, and cytokine secretion. In minimal change disease, B cell-mediated immune dysregulation is primarily characterized by decreased CD19+ cells and increased plasmablasts. Membranous nephropathy patients exhibit increased na\u00efve B cells and decreased memory B cells, while focal segmental glomerulosclerosis is characterized by elevated class-switched memory B cells. These B cell subset alterations can serve as biomarkers for disease activity assessment and prognosis prediction. B cell-targeted therapies, such as anti-CD20 monoclonal antibodies, have demonstrated significant therapeutic efficacy in nephrotic syndrome, further confirming the pivotal role of B cells in its pathogenesis. Different pathological types of NS show significant differences in B cell subset changes, pathogenic mechanisms, and therapeutic responses. Primary and secondary nephrotic syndrome exhibit important distinctions in B cell activation mechanisms, subset imbalance patterns, degree of renal tissue infiltration, and autoantibody profiles. Age factors significantly influence B cell development, function, and therapeutic response, with notable differences between pediatric and adult patients in B cell subset distribution, treatment efficacy, and pharmacokinetics. With the application of emerging technologies such as single-cell sequencing, in-depth analysis of B cell subset characteristics and their interactions with other immune cells will provide new insights for developing more precise diagnostic and therapeutic strategies. However, current methodological heterogeneity challenges in research, including patient population differences, inconsistent B cell subset definitions, technical platform variations, and non-uniform clinical assessment criteria, limit the comparability of research results and clinical applications. Future efforts need to establish standardized B cell monitoring protocols and precision diagnostic systems, develop next-generation B cell-targeted therapeutic strategies, and deeply explore age-specific mechanisms and systems biology research to achieve precision medicine in nephrotic syndrome.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1598197","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T05:28:52Z","timestamp":1754544532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of B lymphocyte subsets in nephrotic syndrome: functions, mechanisms, clinical significance and future perspectives"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuheng","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1434-z","article-title":"Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy","volume":"19","author":"Benz","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3677-5","article-title":"Immunology of idiopathic nephrotic syndrome","volume":"33","author":"Colucci","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B cell responses: cell interaction dynamics and decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.09430915","article-title":"B cells, antibodies, and more","volume":"11","author":"Hoffman","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.07.028","article-title":"A comprehensive phenotypic and functional immune analysis unravels circulating anti-phospholipase A2 receptor antibody secreting cells in membranous nephropathy patients","volume":"5","author":"Cantarelli","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00377","article-title":"Altered B-lymphocyte homeostasis in idiopathic nephrotic syndrome","volume":"7","author":"Ling","year":"2019","journal-title":"Front Pediatr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000341","article-title":"Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: report of 21 cases and review of the literature","volume":"69","author":"Audard","year":"2006","journal-title":"Kidney Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-251132","article-title":"Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes","volume":"115","author":"Audard","year":"2010","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000000206","article-title":"Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases","volume":"93","author":"Kofman","year":"2014","journal-title":"Med (Baltimore)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2016.200","article-title":"Idiopathic nephrotic syndrome: the EBV hypothesis","volume":"81","author":"Dossier","year":"2017","journal-title":"Pediatr Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v13.i4.99643","article-title":"Adult minimal change disease: Clinicopathologic characteristics, treatment response and outcome at a single center in Pakistan","volume":"13","author":"Shakeel","year":"2024","journal-title":"World J Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v13.i1.88028","article-title":"Clinicopathological features and medium-term outcomes of histologic variants of primary focal segmental glomerulosclerosis in adults: A retrospective study","volume":"13","author":"Jafry","year":"2024","journal-title":"World J Nephrol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.586012","article-title":"Rituximab induces complete remission of proteinuria in a patient with minimal change disease and no detectable B cells","volume":"11","author":"Webend\u00f6rfer","year":"2020","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1059740","article-title":"Case report: Successful outcome of treatment using rituximab in an adult patient with refractory minimal change disease and \u03b2-thalassemia complicating autoimmune hemolytic anemia","volume":"9","author":"Zhuang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v13.i4.98932","article-title":"Clinical course and outcome of adult patients with primary focal segmental glomerulosclerosis with kidney function loss on presentation","volume":"13","author":"Jafry","year":"2024","journal-title":"World J Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1516111","article-title":"PM2.5-induced oxidative stress upregulates PLA2R expression in the lung and is involved in the pathogenesis of membranous nephropathy through extracellular vesicles","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.07110810","article-title":"Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement","volume":"6","author":"Sethi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/imna-d-23-00007","article-title":"IgG4-related disease with igG1-dominant membranous nephropathy: A rare case report","volume":"10","author":"Duan","year":"2023","journal-title":"Integr Med Nephrol Andrology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012614","article-title":"Metabolomics profiling of nephrotic syndrome towards biomarker discovery","volume":"23","author":"Jacob","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: modulators of CD4+ T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107839","article-title":"Increased levels of circulating class-switched memory B cells and plasmablasts are associated with serum immunoglobulin G in primary focal segmental glomerulosclerosis patients","volume":"98","author":"Liu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab281","article-title":"Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment","volume":"38","author":"Noris","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149675","article-title":"Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches","volume":"53","author":"Merino-Vico","year":"2023","journal-title":"Eur J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3175","article-title":"Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus","volume":"16","author":"Tipton","year":"2015","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106451","article-title":"Alterations in peripheral blood B cells in systemic lupus erythematosus patients with renal insufficiency","volume":"83","author":"Wardowska","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.138","article-title":"B cells in type 1 diabetes mellitus and diabetic kidney disease","volume":"13","author":"Smith","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199105233242103","article-title":"Membranous nephropathy related to hepatitis B virus in adults","volume":"324","author":"Lai","year":"1991","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01732","article-title":"B cell subsets and cellular signatures and disease relapse in lupus nephritis","volume":"11","author":"Yap","year":"2020","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.09180816","article-title":"Viral-associated GN: hepatitis B and other viral infections","volume":"12","author":"Kupin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1509033","article-title":"Organ-based characterization of B cells in patients with systemic lupus erythematosus","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.046","article-title":"B-cell biology and development","volume":"131","author":"Pieper","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2004.0109.x","article-title":"Peripheral development of B cells in mouse and man","volume":"197","author":"Carsetti","year":"2004","journal-title":"Immunol Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115723","article-title":"Maintenance of serum antibody levels","volume":"23","author":"Manz","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2015050523","article-title":"B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome","volume":"27","author":"Colucci","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.823204","article-title":"B-cell dysregulation in idiopathic nephrotic syndrome: what we know and what we need to discover","volume":"13","author":"Colucci","year":"2022","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.10.027","article-title":"The autoimmune architecture of childhood idiopathic nephrotic syndrome","volume":"107","author":"Al-Aubodah","year":"2025","journal-title":"Kidney Int"},{"key":"B38","doi-asserted-by":"publisher","first-page":"7682","DOI":"10.1038\/s41467-023-43504-8","article-title":"The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome","volume":"14","author":"Al-Aubodah","year":"2023","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-331462","article-title":"Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11+ B-cell population is important for the development of autoimmunity","volume":"118","author":"Rubtsov","year":"2011","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-330530","article-title":"A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice","volume":"118","author":"Hao","year":"2011","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600522","article-title":"Cutting edge: IL-4, IL-21, and IFN-\u03b3 Interact to govern T-bet and CD11c expression in TLR-activated B cells","volume":"197","author":"Naradikian","year":"2016","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00018-022-04433-9","article-title":"Age-associated B cells in autoimmune diseases","volume":"79","author":"Mouat","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1312348110","article-title":"T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance","volume":"110","author":"Rubtsova","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501209","article-title":"Age-associated B cells: A T-bet-dependent effector with roles in protective and pathogenic immunity","volume":"195","author":"Rubtsova","year":"2015","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.10.6624","article-title":"A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus","volume":"178","author":"Wei","year":"2007","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals","volume":"205","author":"Moir","year":"2008","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cellimm.2017.07.003","article-title":"Atypical memory B cells in human chronic infectious diseases: An interim report","volume":"321","author":"Portugal","year":"2017","journal-title":"Cell Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004894","article-title":"FCRL5 delineates functionally impaired memory B cells associated with plasmodium falciparum exposure","volume":"11","author":"Sullivan","year":"2015","journal-title":"PLoS Pathog"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92943","article-title":"T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response","volume":"2","author":"Knox","year":"2017","journal-title":"JCI Insight"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1172\/jci140453","article-title":"Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy","volume":"131","author":"Haddad","year":"2021","journal-title":"J Clin Invest"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad228","article-title":"Novel biomarkers and pathophysiology of membranous nephropathy: PLA2R and beyond","volume":"17","author":"Murtas","year":"2024","journal-title":"Clin Kidney J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41467-023-36068-0","article-title":"The classical pathway triggers pathogenic complement activation in membranous nephropathy","volume":"14","author":"Seifert","year":"2023","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.060554","article-title":"The contribution of B cells to renal interstitial inflammation","volume":"170","author":"Heller","year":"2007","journal-title":"Am J Pathol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nri3383","article-title":"Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes","volume":"13","author":"Cerutti","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa279","article-title":"Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults","volume":"36","author":"Oniszczuk","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2021060794","article-title":"Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2314471","article-title":"Autoantibodies targeting nephrin in podocytopathies","volume":"391","author":"Hengel","year":"2024","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-981-15-3532-1_4","article-title":"Germinal center reaction","volume":"1254","author":"Huang","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-051220-092001","article-title":"Pathogenesis of focal segmental glomerulosclerosis and related disorders","volume":"20","author":"Altintas","year":"2025","journal-title":"Annu Rev Pathol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41581-018-0074-7","article-title":"Effector and regulatory B cells in immune-mediated kidney disease","volume":"15","author":"Oleinika","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"F505","DOI":"10.1152\/ajprenal.00041.2021","article-title":"Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome","volume":"321","author":"Trachtman","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(03)00025-6","article-title":"Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor","volume":"18","author":"Seshasayee","year":"2003","journal-title":"Immunity"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11121569","article-title":"Hepatitis C virus-related central and peripheral nervous system disorders","volume":"11","author":"Moretti","year":"2021","journal-title":"Brain Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00564-1","article-title":"Membranous nephropathy: new pathogenic mechanisms and their clinical implications","volume":"18","author":"Hoxha","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2020071082","article-title":"New \u2018Antigens\u2019 in membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112769","article-title":"B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges","volume":"140","author":"Wu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.01.012","article-title":"B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab","volume":"92","author":"Rosenzwajg","year":"2017","journal-title":"Kidney Int"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T-cell function","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfp087","article-title":"Peripheral CD19+ B cells are increased in children with active steroid-sensitive nephrotic syndrome","volume":"2","author":"Printza","year":"2009","journal-title":"NDT Plus"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2024.06.010","article-title":"Rescue with obinutuzumab and daratumumab as combined B cell\/plasma cell targeting approach in severe posttransplant focal segmental glomerulosclerosis recurrence","volume":"24","author":"Randone","year":"2024","journal-title":"Am J Transplant"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2150451","article-title":"Immunologic changes implicated in the pathogenesis of focal segmental glomerulosclerosis","volume":"2016","author":"Kronbichler","year":"2016","journal-title":"BioMed Res Int"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234934","article-title":"Complement activation profile of patients with primary focal segmental glomerulosclerosis","volume":"15","author":"Huang","year":"2020","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136558","article-title":"Complement activation in patients with focal segmental glomerulosclerosis","volume":"10","author":"Thurman","year":"2015","journal-title":"PLoS One"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1507-0","article-title":"Characterisation of renal immune cell infiltrates in children with nephrotic syndrome","volume":"25","author":"Benz","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277800","article-title":"B-cell activating factor (BAFF) and its receptors\u2019 expression in pediatric nephrotic syndrome is associated with worse prognosis","volume":"17","author":"Forero-Delgadillo","year":"2022","journal-title":"PLoS One"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.05.009","article-title":"The complexity of the BAFF TNF-family members: implications for autoimmunity","volume":"39","author":"LAHIRI","year":"2012","journal-title":"J Autoimmun"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1172\/jci38010","article-title":"The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus","volume":"119","author":"Cancro","year":"2009","journal-title":"J Clin Invest"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7040086","article-title":"Primary membranous glomerulonephritis: the role of serum and urine biomarkers in patient management","volume":"7","author":"Maifata","year":"2019","journal-title":"Biomedicines"},{"key":"B81","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.10.009","article-title":"Membranous nephropathy: core curriculum 2021","volume":"77","author":"Alsharhan","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01148-w","article-title":"Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1\/\u03b2-catenin pathway","volume":"45","author":"Miao","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1333170","article-title":"Mechanisms of inflammation modulation by different immune cells in hypertensive nephropathy","volume":"15","author":"Hao","year":"2024","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154763","article-title":"Moshen granule ameliorates membranous nephropathy by blocking intrarenal renin-angiotensin system signalling via the Wnt1\/\u03b2-catenin pathway","volume":"114","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16219","article-title":"Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites","volume":"181","author":"Miao","year":"2024","journal-title":"Br J Pharmacol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12964-023-01442-4","article-title":"Sirtuins in kidney diseases: potential mechanism and therapeutic targets","volume":"22","author":"Jin","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1404954","article-title":"Overlap of membranous nephropathy and IgA nephropathy in a patient with Kimura\u2019s disease: a case report and literature review","volume":"15","author":"Barbosa","year":"2024","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1097\/imna-d-22-00028","article-title":"Diagnosis of fibrillary glomerulonephritis with positive immunoglobulin A-\u03ba Deposits presenting as membranous nephropathy using immunoelectron microscopy: A case report and literature review","volume":"10","author":"Li","year":"2023","journal-title":"Integr Med Nephrol Andrology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-019-00399-z","article-title":"Membranous nephropathy caused by rheumatoid arthritis","volume":"8","author":"Iida","year":"2019","journal-title":"CEN Case Rep"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.800242","article-title":"How times have changed! A cornucopia of antigens for membranous nephropathy","volume":"12","author":"Caza","year":"2021","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00157","article-title":"Alternative pathway dysregulation and the conundrum of complement activation by igG4 immune complexes in membranous nephropathy","volume":"7","author":"Borza","year":"2016","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1277554","article-title":"Causal relationship between gut microbiota and kidney diseases: a two-sample Mendelian randomization study","volume":"14","author":"Feng","year":"2023","journal-title":"Front Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.909491","article-title":"Specific alterations of gut microbiota in patients with membranous nephropathy: A systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Physiol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1159\/000533537","article-title":"Altered intestinal microbial flora and metabolism in patients with idiopathic membranous nephropathy","volume":"54","author":"Shi","year":"2023","journal-title":"Am J Nephrol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","article-title":"The sirtuin family in health and disease","volume":"7","author":"Wu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1108178","article-title":"Membranoproliferative glomerulonephritis\u2013a new look at an old entity","volume":"366","author":"Sethi","year":"2012","journal-title":"N Engl J Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.217","article-title":"Ectopic lymphoid neogenesis in rheumatic autoimmune diseases","volume":"13","author":"Bombardieri","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2018-0031","article-title":"Rituximab treatment for immune-complex-mediated membranoproliferative glomerulonephritis","volume":"10","author":"Lu","year":"2018","journal-title":"Immunotherapy"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.5414\/cn107299","article-title":"Rituximab therapy for Type I membranoproliferative glomerulonephritis","volume":"77","author":"Dillon","year":"2012","journal-title":"Clin Nephrol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s11255-012-0206-0","article-title":"Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature","volume":"45","author":"Kong","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.09.038","article-title":"Management of hepatitis C virus-related mixed cryoglobulinemia","volume":"123","author":"Iannuzzella","year":"2010","journal-title":"Am J Med"},{"key":"B103","article-title":"Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C","volume":"20","author":"Ahmed","year":"2007","journal-title":"J Nephrol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/art.40396","article-title":"Abnormal B cell development in systemic lupus erythematosus: what the genetics tell us","volume":"70","author":"Karrar","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41584-020-00544-4","article-title":"Toll-like receptor signalling in B cells during systemic lupus erythematosus","volume":"17","author":"Fillatreau","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11892-018-0984-6","article-title":"Role of the immune system in diabetic kidney disease","volume":"18","author":"Hickey","year":"2018","journal-title":"Curr Diabetes Rep"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S457526","article-title":"The role of immune cells in DKD: mechanisms and targeted therapies","volume":"17","author":"Peng","year":"2024","journal-title":"J Inflammation Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i5.712","article-title":"Existence and significance of hepatitis B virus DNA in kidneys of IgA nephropathy","volume":"11","author":"Wang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.869284","article-title":"Intrarenal single-cell sequencing of hepatitis B virus associated membranous nephropathy","volume":"9","author":"Yu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B110","doi-asserted-by":"publisher","first-page":"i7","DOI":"10.1093\/ndt\/gfw235","article-title":"Clinical trials in minimal change disease","volume":"32","author":"Ravani","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.05950809","article-title":"Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome","volume":"4","author":"Niaudet","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B112","article-title":"Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center","volume":"72","author":"Fujinaga","year":"2009","journal-title":"Clin Nephrol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.krcp.2012.10.003","article-title":"The use of tacrolimus in the management of minimal change disease","volume":"31","author":"Bum","year":"2012","journal-title":"Kidney Res Clin Pract"},{"key":"B114","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12882-020-01797-7","article-title":"Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis","volume":"21","author":"Hansrivijit","year":"2020","journal-title":"BMC Nephrol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae139","article-title":"The efficacy and safety of rituximab with or without glucocorticoid in inducing remission of MCD with different clinical presentations in adults: a retrospective study","volume":"17","author":"Sun","year":"2024","journal-title":"Clin Kidney J"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2013030251","article-title":"Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome","volume":"25","author":"Ruggenenti","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01404-7","article-title":"Poria cocos: traditional uses, triterpenoid components and their renoprotective pharmacology","volume":"46","author":"Guo","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1430356","article-title":"Exploration of the pathogenesis of nephrotic syndrome and traditional Chinese medicine intervention based on gut microbiota","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/ijnrd.S126844","article-title":"Optimal management of primary focal segmental glomerulosclerosis in adults","volume":"10","author":"Beaudreuil","year":"2017","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2020.415","article-title":"Single-cell transcriptomics: a novel precision medicine technique in nephrology","volume":"36","author":"Kim","year":"2021","journal-title":"Korean J Intern Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.4.655","article-title":"Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up","volume":"17","author":"Segarra","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308550","article-title":"Sparsentan versus irbesartan in focal segmental glomerulosclerosis","volume":"389","author":"Rheault","year":"2023","journal-title":"N Engl J Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-007-0640-x","article-title":"Rituximab for refractory focal segmental glomerulosclerosis","volume":"23","author":"Nakayama","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2024.100844","article-title":"The pursuit of new treatments for focal segmental glomerulosclerosis: harmonizing innovation with the DUET study of sparsentan","volume":"6","author":"Mishra","year":"2024","journal-title":"Kidney Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1386604","article-title":"Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1097\/imna-d-23-00004","article-title":"Use of chinese herbal medicine to inhibit podocyte damage as therapeutic strategy for membranous nephropathy","volume":"10","author":"Zhang","year":"2023","journal-title":"Integr Med Nephrol Andrology"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1097\/imna-d-22-00010","article-title":"The combination therapy of glucocorticoids, tacrolimus, and mycophenolate mofetil in primary membranous nephropathy coexisting with type 2 diabetes mellitus: A retrospective study","volume":"10","author":"Wang","year":"2023","journal-title":"Integr Med Nephrol Andrology"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0683-z","article-title":"Efficacy and safety of tacrolimus versus cyclophosphamide for primary membranous nephropathy: A meta-analysis","volume":"77","author":"Zhu","year":"2017","journal-title":"Drugs"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.12.005","article-title":"Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials","volume":"16","author":"Qiu","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1681\/asn.V93444","article-title":"A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy","volume":"9","author":"Ponticelli","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2016040449","article-title":"Rituximab for severe membranous nephropathy: A 6-month trial with extended follow-up","volume":"28","author":"Dahan","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N Engl J Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.01180307","article-title":"Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy","volume":"2","author":"Cravedi","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01656-1","article-title":"Recent clinical trials insights into the treatment of primary membranous nephropathy","volume":"82","author":"Rojas-Rivera","year":"2022","journal-title":"Drugs"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1543581","article-title":"Low-dose cyclophosphamide combined with chinese herbal medicine Shuli Fenxiao formula for the treatment of intermediate-to-high risk primary membranous nephropathy","volume":"16","author":"Du","year":"2025","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1391675","article-title":"Efficacy and safety of Chinese herbal medicines combined with biomedicine in the treatment of idiopathic membranous nephropathy: a systematic review and network meta-analysis","volume":"15","author":"Zhu","year":"2024","journal-title":"Front Pharmacol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1097\/imna-d-23-00009","article-title":"Homeostatic modulation of CD4+ T cell subsets using the chinese medicine jianpi qushi heluo formula during the alleviation of primary membranous nephropathy","volume":"10","author":"Zeng","year":"2023","journal-title":"Integr Med Nephrol Andrology"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108904","article-title":"Sanqi oral solution ameliorates renal damage and restores podocyte injury in experimental membranous nephropathy via suppression of NF\u03baB","volume":"115","author":"Tian","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102671","article-title":"Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown","volume":"19","author":"Gauckler","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1172\/jci72270","article-title":"Membranous nephropathy: from models to man","volume":"124","author":"Beck","year":"2014","journal-title":"J Clin Invest"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac687","article-title":"A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients","volume":"62","author":"Parkes","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B143","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1590\/2175-8239-jbn-2018-0254","article-title":"Rituximab use in adult glomerulopathies and its rationale","volume":"42","author":"Santos","year":"2020","journal-title":"J Bras Nefrol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04206.x","article-title":"Reference values for B cell subpopulations from infancy to adulthood","volume":"162","author":"Morbach","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.jaci.2018.02.017","article-title":"Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood","volume":"141","author":"Blanco","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2012.02671.x","article-title":"Paediatric reference values for the peripheral T cell compartment","volume":"75","author":"Schatorj\u00e9","year":"2012","journal-title":"Scand J Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"282","author":"Simon","year":"2015","journal-title":"Proc Biol Sci"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses","volume":"131","author":"Van De Veen","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/nri2075","article-title":"Innate immunity of the newborn: basic mechanisms and clinical correlates","volume":"7","author":"Levy","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-4095-z","article-title":"B cell phenotype in pediatric idiopathic nephrotic syndrome","volume":"34","author":"Colucci","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1159\/000511319","article-title":"Decreased circulating transitional B-cell to memory B-cell ratio is a risk factor for relapse in children with steroid-sensitive nephrotic syndrome","volume":"145","author":"Ling","year":"2021","journal-title":"Nephron"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome","volume":"84","author":"Ravani","year":"2013","journal-title":"Kidney Int"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2014080799","article-title":"Rituximab in children with steroid-dependent nephrotic syndrome: A multicenter, open-label, noninferiority, randomized controlled trial","volume":"26","author":"Ravani","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr405","article-title":"Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood\u2013follow-up after CD19 recovery","volume":"27","author":"Sellier-Leclerc","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.04.009","article-title":"B cell repertoire and ageing","volume":"22","author":"Dunn-Walters","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"Lebien","year":"2008","journal-title":"Blood"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.741796","article-title":"Asymptomatic and mild SARS-coV-2 infections elicit lower immune activation and higher specific neutralizing antibodies in children than in adults","volume":"12","author":"Petrara","year":"2021","journal-title":"Front Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-012-2310-x","article-title":"Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.34","article-title":"Membranous nephropathy: recent travels and new roads ahead","volume":"77","author":"Beck","year":"2010","journal-title":"Kidney Int"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.01.008","article-title":"The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey","volume":"56","author":"Glassock","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.232","article-title":"A glomerular permeability factor produced by human T cell hybridomas","volume":"40","author":"Koyama","year":"1991","journal-title":"Kidney Int"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu035","article-title":"Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist","volume":"30","author":"Sethi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B166","article-title":"Diagnosis and management of nephrotic syndrome in adults","volume":"93","author":"Kodner","year":"2016","journal-title":"Am Fam Physician"},{"key":"B167","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/sonc.2002.30156","article-title":"Rituximab: mechanism of action and resistance","volume":"29","author":"Maloney","year":"2002","journal-title":"Semin Oncol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363080-00005","article-title":"Rituximab: a review of its use in non-Hodgkin\u2019s lymphoma and chronic lymphocytic leukaemia","volume":"63","author":"Plosker","year":"2003","journal-title":"Drugs"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01486.x","article-title":"Low-dose rituximab in adult patients with primary immune thrombocytopenia","volume":"85","author":"Zaja","year":"2010","journal-title":"Eur J Haematol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1086\/345746","article-title":"Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment","volume":"36","author":"Quartier","year":"2003","journal-title":"Clin Infect Dis"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3780-7","article-title":"Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options","volume":"33","author":"Kemper","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1007\/s001090050206","article-title":"Regulation of podocyte structure during the development of nephrotic syndrome","volume":"76","author":"Smoyer","year":"1998","journal-title":"J Mol Med (Berl)"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-0486","article-title":"Mycophenolate mofetil following rituximab in children with steroid-resistant nephrotic syndrome","volume":"136","author":"Basu","year":"2015","journal-title":"Pediatrics"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/jir.S124947","article-title":"Urinary excretion of IL-1\u03b2, IL-6 and IL-8 cytokines during relapse and remission of idiopathic nephrotic syndrome","volume":"10","author":"Al-Eisa","year":"2017","journal-title":"J Inflammation Res"},{"key":"B176","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2215\/cjn.04120417","article-title":"Whole exome sequencing of patients with steroid-resistant nephrotic syndrome","volume":"13","author":"Warejko","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02633-5","article-title":"Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis","volume":"53","author":"Huang","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1172\/jci149095","article-title":"Meant to B: B cells as a therapeutic target in systemic lupus erythematosus","volume":"131","author":"Atisha-Fregoso","year":"2021","journal-title":"J Clin Invest"},{"key":"B179","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/nep.12744","article-title":"Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease","volume":"21","author":"Papakrivopoulou","year":"2016","journal-title":"Nephrol (Carlton)"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-013-2534-4","article-title":"Rituximab in idiopathic nephrotic syndrome: does it make sense","volume":"29","author":"Cara-Fuentes","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2022.113327","article-title":"Flow cytometry for B-cell subset analysis in immunodeficiencies","volume":"509","author":"Kum\u00e1novics","year":"2022","journal-title":"J Immunol Methods"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.06.013","article-title":"Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing\/steroid-dependent nephrotic syndrome","volume":"104","author":"Colucci","year":"2023","journal-title":"Kidney Int"},{"key":"B183","article-title":"CD20-positive infiltrates in human membranous glomerulonephritis","volume":"18","author":"Cohen","year":"2005","journal-title":"J Nephrol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901465","article-title":"Increased proportion of follicular helper T cells is associated with B cell activation and disease severity in IgA nephropathy","volume":"13","author":"Du","year":"2022","journal-title":"Front Immunol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.726428","article-title":"CyTOF-enabled analysis identifies class-switched B cells as the main lymphocyte subset associated with disease relapse in children with idiopathic nephrotic syndrome","volume":"12","author":"Fribourg","year":"2021","journal-title":"Front Immunol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.00570109","article-title":"Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis","volume":"4","author":"Fernandez-Fresnedo","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.kint.2019.09.033","article-title":"Both the rituximab dose and maintenance immunosuppression in steroid-dependent\/frequently-relapsing nephrotic syndrome have important effects on outcomes","volume":"97","author":"Chan","year":"2020","journal-title":"Kidney Int"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.05.032","article-title":"B-cell repertoire and functions in idiopathic nephrotic syndrome: what to learn from single-cell RNA sequencing","volume":"106","author":"Dorval","year":"2024","journal-title":"Kidney Int"},{"key":"B189","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000535010","article-title":"Efficacy of rituximab for minimal change disease and focal segmental glomerulosclerosis with frequently relapsing or steroid-dependent nephrotic syndrome in adults: A chinese multicenter retrospective study","volume":"55","author":"Lan","year":"2024","journal-title":"Am J Nephrol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00415-018-9092-4","article-title":"Peripheral CD19(+) B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica\/neuromyelitis optica spectrum disorders","volume":"266","author":"Ellrichmann","year":"2019","journal-title":"J Neurol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-006-0427-5","article-title":"Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome","volume":"22","author":"Smith","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.1","article-title":"Long-lived autoreactive plasma cells drive persistent autoimmune inflammation","volume":"7","author":"Hiepe","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2019.09.004","article-title":"B cell targeted therapies in autoimmune disease","volume":"61","author":"Barnas","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11074","article-title":"Patterns of B cell repletion following rituximab therapy in a pediatric rheumatology cohort","volume":"1","author":"Mitchell","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"B195","article-title":"B lymphocyte subset patterns and their significance in idiopathic glomerulonephritis","volume":"48","author":"Tani","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad215","article-title":"Molecular characteristics of circulating B cells and kidney cells at the single-cell level in special types of primary membranous nephropathy","volume":"16","author":"Feng","year":"2023","journal-title":"Clin Kidney J"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.07180622","article-title":"The immune system and idiopathic nephrotic syndrome","volume":"17","author":"Campbell","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1335936","article-title":"Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Immunol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.08570722","article-title":"Use of rituximab in childhood idiopathic nephrotic syndrome","volume":"18","author":"Chan","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"B200","article-title":"Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis","volume":"35","author":"Giollo","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.444","article-title":"Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease","volume":"83","author":"Munyentwali","year":"2013","journal-title":"Kidney Int"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy239","article-title":"Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis","volume":"141","author":"Baker","year":"2018","journal-title":"Brain"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12050300","article-title":"Chronic kidney disease-associated immune dysfunctions: impact of protein-bound uremic retention solutes on immune cells","volume":"12","author":"Espi","year":"2020","journal-title":"Toxins (Basel)"},{"key":"B204","doi-asserted-by":"publisher","first-page":"20230877","DOI":"10.1515\/med-2023-0877","article-title":"The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study","volume":"18","author":"Pang","year":"2023","journal-title":"Open Med (Wars)"},{"key":"B205","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12176","article-title":"B10 cell regulation of health and disease","volume":"259","author":"Candando","year":"2014","journal-title":"Immunol Rev"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.10.023","article-title":"Optimization of rituximab therapy in adult patients with PLA2R1-associated membranous nephropathy with artificial intelligence","volume":"9","author":"Destere","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1090241","article-title":"Machine learning models for predicting steroid-resistant of nephrotic syndrome","volume":"14","author":"Ye","year":"2023","journal-title":"Front Immunol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1681\/asn.2012020187","article-title":"IgM contributes to glomerular injury in FSGS","volume":"24","author":"Strassheim","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.90421.2008","article-title":"Inducible rodent models of acquired podocyte diseases","volume":"296","author":"Pippin","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"12297","DOI":"10.1038\/s41598-022-16333-w","article-title":"Protective effects of rituximab on puromycin-induced apoptosis, loss of adhesion and cytoskeletal alterations in human podocytes","volume":"12","author":"Jeruschke","year":"2022","journal-title":"Sci Rep"},{"key":"B213","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/nep.12737","article-title":"Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes","volume":"22","author":"Takahashi","year":"2017","journal-title":"Nephrol (Carlton)"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-021-03454-3","article-title":"Immune-mediated entities of (primary) focal segmental glomerulosclerosis","volume":"385","author":"Braun","year":"2021","journal-title":"Cell Tissue Res"},{"key":"B215","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.trsl.2021.03.019","article-title":"Low regulatory T-cells: A distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy","volume":"235","author":"Chan","year":"2021","journal-title":"Transl Res"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413560","article-title":"B cells in primary membranous nephropathy: escape from immune tolerance and implications for patient management","volume":"22","author":"So","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B217","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s10020-023-00693-8","article-title":"Single-cell RNA sequencing for the study of kidney disease","volume":"29","author":"Zhu","year":"2023","journal-title":"Mol Med"},{"key":"B218","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3390\/jpm14121157","article-title":"Decoding kidney pathophysiology: omics-driven approaches in precision medicine","volume":"14","author":"Delrue","year":"2024","journal-title":"J Pers Med"},{"key":"B219","author":"ZHOU","year":""},{"key":"B220","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12882-024-03853-y","article-title":"The advance of single cell transcriptome to study kidney immune cells in diabetic kidney disease","volume":"25","author":"Wang","year":"2024","journal-title":"BMC Nephrol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.4172\/jpb.1000102","article-title":"LC-MS based detection of differential protein expression","volume":"2","author":"Tuli","year":"2009","journal-title":"J Proteomics Bioinform"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201900226","article-title":"Deep profiling of cellular heterogeneity by emerging single-cell proteomic technologies","volume":"20","author":"Yang","year":"2020","journal-title":"Proteomics"},{"key":"B223","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12916-025-03920-7","article-title":"Metabolomics- and proteomics-based multi-omics integration reveals early metabolite alterations in sepsis-associated acute kidney injury","volume":"23","author":"Huang","year":"2025","journal-title":"BMC Med"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1053850","article-title":"Single-cell transcriptomics: A new tool for studying diabetic kidney disease","volume":"13","author":"Mao","year":"2022","journal-title":"Front Physiol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"7634","DOI":"10.1038\/s41467-022-35297-z","article-title":"Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity","volume":"13","author":"Mcevoy","year":"2022","journal-title":"Nat Commun"},{"key":"B226","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41467-019-09092-2","article-title":"A late B lymphocyte action in dysfunctional tissue repair following kidney injury and transplantation","volume":"10","author":"Cipp\u00e0","year":"2019","journal-title":"Nat Commun"},{"key":"B227","article-title":"Immunodynamics of minimal change nephrotic syndrome in adults T and B lymphocyte subsets and serum immunoglobulin levels","volume":"61","author":"Yokoyama","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-013-2679-1","article-title":"CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance","volume":"29","author":"Cara-Fuentes","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2017.1385775","article-title":"Higher frequencies of circulating ICOS(+), IL-21(+) T follicular helper cells and plasma cells in patients with new-onset membranous nephropathy","volume":"50","author":"Zhang","year":"2017","journal-title":"Autoimmunity"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1101\/2023.08.14.23292885","article-title":"predictive and prognostic value of peripheral blood antigen-specific memory B cells in phospholipase A2 receptor-associated membranous nephropathy","author":"Zhu","year":"2023","journal-title":"medRxiv"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2024.106838","article-title":"Alterations of B-cell subsets in peripheral blood from adult patients with idiopathic membranous nephropathy","volume":"266","author":"Wang","year":"2024","journal-title":"Immunol Lett"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-023-01838-5","article-title":"Imbalance of T follicular helper cell subsets trigger the differentiation of pathogenic B cells in idiopathic membranous nephropathy","volume":"73","author":"Deng","year":"2024","journal-title":"Inflammation Res"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304360","article-title":"Btg2 promotes focal segmental glomerulosclerosis via smad3-dependent podocyte-mesenchymal transition","volume":"10","author":"Dan Hu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097687","article-title":"Immunophenotypic alterations in adult patients with steroid-dependent and frequently relapsing nephrotic syndrome","volume":"24","author":"Casiraghi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B235","doi-asserted-by":"publisher","first-page":"13083","DOI":"10.1038\/s41598-021-92573-6","article-title":"The immune cell landscape of peripheral blood mononuclear cells from PNS patients","volume":"11","author":"Ye","year":"2021","journal-title":"Sci Rep"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.07.001","article-title":"Circulating follicular T helper cells are possibly associated with low levels of serum immunoglobulin G due to impaired immunoglobulin class-switch recombination of B cells in children with primary nephrotic syndrome","volume":"114","author":"Yang","year":"2019","journal-title":"Mol Immunol"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1379924","article-title":"A novel flow cytometry panel to identify prognostic markers for steroid-sensitive forms of idiopathic nephrotic syndrome in childhood","volume":"15","author":"Riganati","year":"2024","journal-title":"Front Immunol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246231","article-title":"B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments","volume":"20","author":"Yap","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B239","article-title":"Nephrotic syndrome in adults: diagnosis and management","volume":"80","author":"Kodner","year":"2009","journal-title":"Am Fam Physician"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143393","article-title":"Unraveling the role of inflammation in the pathogenesis of diabetic kidney disease","volume":"20","author":"Matoba","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.614","article-title":"Membranous nephropathy: pathogenesis and treatments","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm (2020)"},{"key":"B242","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/147323001103900111","article-title":"Correlation between B lymphocyte abnormality and disease activity in patients with idiopathic membranous nephropathy","volume":"39","author":"Wang","year":"2011","journal-title":"J Int Med Res"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-022-02336-w","article-title":"B cell phenotype, activity, and function in idiopathic nephrotic syndrome","volume":"93","author":"Liu","year":"2023","journal-title":"Pediatr Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1598197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T05:28:56Z","timestamp":1754544536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1598197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":243,"alternative-id":["10.3389\/fimmu.2025.1598197"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1598197","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"article-number":"1598197"}}